Use of CSF biomarkers in Alzheimer’s disease clinical trials

被引：0
|
作者：
K. Blennow
H. Zetterberg
机构：
[1] the Sahlgrenska Academy at Göteborg University,Clinical Neurochemistry Laboratory
[2] The Sahlgrenska Academy at Göteborg University,Clinical Neurochemistry Lab
[3] Sahlgrenska University Hospital,undefined
来源：
JNHA - The Journal of Nutrition, Health and Aging | 2009年 / 13卷
关键词：
Mild Cognitive Impairment; Lewy Body Dementia; BACE1 Inhibitor; Secretase Inhibitor; Mild Cognitive Impairment Case;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
    Van Hulle, Carol
    Jonaitis, Erin M.
    Betthauser, Tobey J.
    Batrla, Richard
    Wild, Norbert
    Kollmorgen, Gwendlyn
    Andreasson, Ulf
    Okonkwo, Ozioma
    Bendlin, Barbara B.
    Asthana, Sanjay
    Carlsson, Cynthia M.
    Johnson, Sterling C.
    Zetterberg, Henrik
    Blennow, Kaj
    ALZHEIMERS & DEMENTIA, 2021, 17 (03) : 431 - 445
  • [22] Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer's Disease: The Paradigmatic Example of CSF
    Canevelli, Marco
    Bacigalupo, Ilaria
    Gervasi, Giuseppe
    Lacorte, Eleonora
    Massari, Marco
    Mayer, Flavia
    Vanacore, Nicola
    Cesari, Matteo
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
  • [23] CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment
    Blennow, K
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2005, 5 (05) : 661 - 672
  • [24] Recognizing Atypical Presentations of Alzheimer's Disease: The Importance of CSF Biomarkers in Clinical Practice
    Paraskevas, George P. P.
    Constantinides, Vasilios C. C.
    Boufidou, Fotini
    Tsantzali, Ioanna
    Pyrgelis, Efstratios-Stylianos
    Liakakis, Georgios
    Kapaki, Elisabeth
    DIAGNOSTICS, 2022, 12 (12)
  • [25] Influence of APOE ε4 on performance of CSF biomarkers in differentiating clinical Alzheimer's disease
    Wang, Yan
    Li, Fangyu
    Qin, Qi
    Li, Tingting
    Wang, Qi
    Li, Yan
    Li, Ying
    Jia, Jianping
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2025, 12 (04): : 100065
  • [26] Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application
    Yang, Jianwei
    Jia, Longfei
    Li, Yan
    Qiu, Qiongqiong
    Quan, Meina
    Jia, Jianping
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 81 (01) : 19 - 32
  • [27] Alzheimer's disease biomarkers and their current use in clinical research and practice
    Hunter, Tai R.
    Santos, Luis E.
    Tovar-Moll, Fernanda
    De Felice, Fernanda G.
    MOLECULAR PSYCHIATRY, 2025, 30 (01) : 272 - 284
  • [28] Current Biomarkers for Alzheimer's Disease: From CSF to Blood
    Zou, Kun
    Abdullah, Mohammad
    Michikawa, Makoto
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (03): : 1 - 15
  • [29] Biomarkers for the Diagnosis of Alzheimer's Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
    Dulewicz, Maciej
    Kulczynska-Przybik, Agnieszka
    Mroczko, Piotr
    Kornhuber, Johannes
    Lewczuk, Piotr
    Mroczko, Barbara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [30] CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease
    Rosenmann, Hanna
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 47 (01) : 1 - 14
12345